Asamedic
Følg pressemeldinger fra Asamedic
Registrer deg med din e-postadresse for å få de nyeste sakene fra Asamedic på e-post fortløpende. Du kan melde deg av når som helst.
Geir Ivar WestenCEO
Tel:90 54 60 49ceo@asamedic.noAsamedic is a Norwegian company established by Per Erik Stribolt-Halvorsen, Geir Ivar Westen and Tore Ritter Westen in 2013. The company began full operations in 2015.
The company was established with the purpose of finding a way to reduce mortality from heart attacks. Through research and innovation Asamedic aims to contribute to save lives.
Asamedic reached end of DCP procedure for its product Coxor with positive outcome in January 2021 and Marketing Authorization in Norway and Denmark has been granted.
- Asamedic
- Rosenholmveien 25
- 1414 Trollåsen
- +47 66 89 00 00
- www.asamedic.com
Pressemeldinger
5
MenyNorwegian-developed heart medicine with a major agreement in Greece5.1.2024 12:28:52 CET | Pressemelding
The Norwegian pharmaceutical company Asamedic AS has entered into a 10-year exclusive licensing agreement with Innovis Pharma for the sale of Coxor® in Greece. This is the second license agreement in a short period outside the Nordics.
Norskutviklet hjertemedisin med stor avtale i Hellas5.1.2024 12:22:30 CET | Pressemelding
Det norske legemiddelselskapet Asamedic AS har inngått en eksklusiv lisensavtale på 10 år med Innovis Pharma for salg av Coxor® i Hellas. Dette er den andre lisensavtalen på kort tid utenfor Norden.
Innovative Norwegian heart medication set for launch in South Africa15.11.2023 15:33:34 CET | Pressemelding
The Norwegian pharmaceutical company Asamedic AS has entered an agreement with the pharmaceutical company Nova Scotia Group (NSG) in South Africa. The over-the-counter drug Coxor was first launched in Norway in January and is to be used immediately in suspected heart attacks.
Norskutviklet hjertemedisin skal selges i Sør-Afrika15.11.2023 15:10:18 CET | Pressemelding
Det norske legemiddelselskapet Asamedic lanserte i januar i år Coxor, et reseptfritt legemiddel som skal brukes umiddelbart ved mistanke om hjerteinfarkt. Nå har de inngått en lisensavtale med legemiddelselskapet Nova Scotia Group (NSG) om markedsrettighetene for Sør-Afrika.
Verdens hjertedag: 30 000 nordmenn har sikret seg denne norskutviklede medisinen mot akutt hjerteinfarkt.29.9.2023 08:52:15 CEST | Pressemelding
Blir du rammet av hjerteinfarkt, teller hvert eneste sekund. Jo tidligere behandlingen starter, jo større er sjansen for å overleve. Dette har 30 000 nordmenn tatt konsekvensen av ved å sikre seg flytende acetylsalisylsyre.
Asamedic is a Norwegian company established by Per Erik Stribolt-Halvorsen, Geir Ivar Westen and Tore Ritter Westen in 2013. The company began full operations in 2015.
The company was established with the purpose of finding a way to reduce mortality from heart attacks. Through research and innovation Asamedic aims to contribute to save lives.
Asamedic reached end of DCP procedure for its product Coxor with positive outcome in January 2021 and Marketing Authorization in Norway and Denmark has been granted.
- Asamedic
- Rosenholmveien 25
- 1414 Trollåsen
- +47 66 89 00 00
- www.asamedic.com